Effectiveness of automated alerting system compared to usual care for the management of sepsis.
Zhongheng ZhangLin ChenPing XuQing WangJianjun ZhangKun ChenCasey M ClementsLeo Anthony CeliVitaly HerasevichYucai HongPublished in: NPJ digital medicine (2022)
There is a large body of evidence showing that delayed initiation of sepsis bundle is associated with adverse clinical outcomes in patients with sepsis. However, it is controversial whether electronic automated alerts can help improve clinical outcomes of sepsis. Electronic databases are searched from inception to December 2021 for comparative effectiveness studies comparing automated alerts versus usual care for the management of sepsis. A total of 36 studies are eligible for analysis, including 6 randomized controlled trials and 30 non-randomized studies. There is significant heterogeneity in these studies concerning the study setting, design, and alerting methods. The Bayesian meta-analysis by using pooled effects of non-randomized studies as priors shows a beneficial effect of the alerting system (relative risk [RR]: 0.71; 95% credible interval: 0.62 to 0.81) in reducing mortality. The automated alerting system shows less beneficial effects in the intensive care unit (RR: 0.90; 95% CI: 0.73-1.11) than that in the emergency department (RR: 0.68; 95% CI: 0.51-0.90) and ward (RR: 0.71; 95% CI: 0.61-0.82). Furthermore, machine learning-based prediction methods can reduce mortality by a larger magnitude (RR: 0.56; 95% CI: 0.39-0.80) than rule-based methods (RR: 0.73; 95% CI: 0.63-0.85). The study shows a statistically significant beneficial effect of using the automated alerting system in the management of sepsis. Interestingly, machine learning monitoring systems coupled with better early interventions show promise, especially for patients outside of the intensive care unit.
Keyphrases
- machine learning
- septic shock
- case control
- acute kidney injury
- intensive care unit
- deep learning
- emergency department
- high throughput
- systematic review
- big data
- randomized controlled trial
- artificial intelligence
- healthcare
- palliative care
- double blind
- open label
- phase iii
- newly diagnosed
- type diabetes
- meta analyses
- placebo controlled
- single cell
- quality improvement
- physical activity
- cardiovascular disease
- patient reported outcomes
- study protocol